In addition, O-acyltransferase 1 (SOAT1) is upregulated in HCC patients with a poor prognosis, whereas inhibiting SOAT1 significantly reduces the size of tumors when SOAT1 expression is high (32). This evidence concerns the gene SOAT1 and hepatocellular carcinoma.